American Diabetes Association

TABLE 3

Individual measured fatty acid rate of appearance (R_a) in plasma during basal conditions and during epinephrine and insulin infusions

	R_a (μmol · kg⁻¹ · min⁻¹)
	Basal	Epinephrine^*	Insulin	Epinephrine	Insulin
Myristate	0.09 ± 0.01	0.40 ± 0.02^†	0.02 ± 0.00^†	373 ± 54^b	20 ± 3^ac
Palmitate	0.99 ± 0.11	3.47 ± 0.44^†	0.20 ± 0.02^†	368 ± 52^b	21 ± 2^c
Stearate	0.32 ± 0.03	0.80 ± 0.06^†	0.08 ± 0.01^†	266 ± 30	25 ± 1
Oleate	1.36 ± 0.19	6.13 ± 0.52^†	0.20 ± 0.02^†	492 ± 67^a	16 ± 1^b
Linoleate	0.68 ± 0.10	2.53 ± 0.36^†	0.11 ± 0.01^†	402 ± 60^ab	17 ± 1^ab
Sum	3.44 ± 0.45	13.30 ± 1.30^†	0.61 ± 0.06^†	413 ± 54^ab	19 ± 1^c

	R_a (μmol · kg⁻¹ · min⁻¹)
	Basal	Epinephrine^*	Insulin	Epinephrine	Insulin
Myristate	0.09 ± 0.01	0.40 ± 0.02^†	0.02 ± 0.00^†	373 ± 54^b	20 ± 3^ac
Palmitate	0.99 ± 0.11	3.47 ± 0.44^†	0.20 ± 0.02^†	368 ± 52^b	21 ± 2^c
Stearate	0.32 ± 0.03	0.80 ± 0.06^†	0.08 ± 0.01^†	266 ± 30	25 ± 1
Oleate	1.36 ± 0.19	6.13 ± 0.52^†	0.20 ± 0.02^†	492 ± 67^a	16 ± 1^b
Linoleate	0.68 ± 0.10	2.53 ± 0.36^†	0.11 ± 0.01^†	402 ± 60^ab	17 ± 1^ab
Sum	3.44 ± 0.45	13.30 ± 1.30^†	0.61 ± 0.06^†	413 ± 54^ab	19 ± 1^c

Data are means ± SE.

Peak value during epinephrine infusion;

†

P < 0.01 vs. corresponding basal value. Values representing the percent change from basal during either epinephrine or insulin infusion that share the same letter as other values in that column are not significantly different; values that do not share the same letter in a column are significantly different (P < 0.05).

View Large

This Feature Is Available To Subscribers Only